2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $988M | $1.2B | $1.4B | $1.7B | $2B |
Cost of Revenue | $650M | $861M | $950M | $1.1B | $1.3B |
Gross Profit | $338M | $386M | $422M | $530M | $707M |
Gross Profit % | 34% | 31% | 31% | 32% | 35% |
R&D Expenses | $9.4M | $11M | $11M | $12M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $100M | $114M | $116M | $166M | $247M |
Dep. & Amort. | $25M | $54M | $21M | $28M | $37M |
Def. Tax | -$3.3M | -$1.5M | -$4M | -$6M | -$8.7M |
Stock Comp. | $2.5M | $4.6M | $9.8M | $14M | $21M |
Chg. in WC | -$33M | $50M | -$141M | $12M | -$98M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $49M | $153M | $36M | $48M | $71M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $49M | $153M | $36M | $48M | $71M |
Receivables | $83M | $104M | $173M | $168M | $220M |
Inventory | $151M | $118M | $200M | $194M | $286M |
BRBR reported strong Q1 results with net sales growing 24% and adjusted EBITDA increasing 25%, driven by Premier Protein's performance.
The company raised its full-year guidance, now expecting net sales growth of 13-17% and adjusted EBITDA growth of 7-14%, with healthy adjusted EBITDA margins of 21.1% at the midpoint.
Premier Protein continues to lead the ready-to-drink (RTD) segment with a 26% market share, driving category growth through distribution expansion, promotional activity, and innovation, including new indulgent product lines.
Marketing efforts, including a new national campaign and packaging redesign, are expected to further boost brand visibility and consumer engagement, with marketing spend increasing throughout the year.
Dymatize's international business showed strong growth, offsetting domestic headwinds, while the company remains cautious about rising protein costs impacting margins later in the fiscal year.